18F-FDG-PET to Discriminate Biologically Malignant Pancreatic Neuroendocrine Tumors Abstract #1690

Introduction: 18F-FDG-PET is widely used to detect malignant tumors. However, the efficacy for pancreatic neuroendocrine tumors (PNETs) is reported to be limited in the clinical practice.
Aim(s): In this study, we reassessed the clinical significance of detection of PNET by 18F-FDG-PET.
Materials and methods: We retrospectively reviewed patients with PNETs who were treated at Kyoto University Hospital between January 2007 and December 2016. Patient’s backgrounds, clinical course and imaging were collected from the medical records. We compared the findings of images, including 18F-FDG-PET, between patients with or without metastatic diseases.
Conference: 14th Annual ENETS conference 2017 (2017)
Category: Imaging (radiology, nuclear medicine, endoscopy)
Presenting Author: MD Asahi Sato

To read results and conclusion, please login ...

Further abstracts you may be interested in

No result